The UK is now losing more working days to flu, cough and cold-related infections than Covid-19, new data show.
Scientists have suggested that the sudden increase in “super colds” forcing people out of work is linked to the pandemic lockdowns and a loss in immunity to respiratory diseases.
It comes as a surge in respiratory infections is sweeping the population and, in the case of influenza, driving an increase in hospital admissions.
hVIVO plc (formerly Open Orphan plc) is a rapidly growing specialist contract research organisation (CRO) and the world leader in testing infectious and respiratory disease vaccines and antivirals using human challenge clinical trials, providing end-to-end early clinical development services for its broad and long-standing client base of biopharma companies.